Precigen, Inc. (PGEN): Operatsion marja

Precigen (PGEN) grafik logotipi

Precigen, Inc. (PGEN) yetakchi biologlar va genetiklarni birlashtirib, irsiy patologiyalar uchun davolash usullarini kashf etish maqsadida ularni saxovatli grantlar bilan rag'batlantiradi. Biznes muvaffaqiyati yuqori R&D xarajatlari fonida respirator terapiya sinovlarining natijalariga bog'liqdir. Moddalar ishlab chiqarish va klinik sinovlar tashqi CRO va CMO hamkorlariga topshirilgan. Operatsion marja joriy daromadlilikni aks ettiradi, bunda parametr belgisi 21.40 ga tengdir.

PGEN: precigen.com Operatsion faoliyat rentabelligi 04.07.2022 - 19.11.2026

precigen.com (PGEN) kompaniyasi koʻrsatkichlari kesimi va tahlili

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning umumiy tahlili:Intrexon
Precigen, Inc. tayyor mahsulotlari

Operatsion marja, foizlar va soliqlar to'lanishidan oldin asosiy operatsiyalardan olingan foydaning tushumga nisbatan ulushini aniqlash orqali xarajatlarni boshqarish samaradorligini o'lchaydi. Ushbu ko'rsatkich biznesning qarz yuklamasidan qat'i nazar, pul oqimini yaratish qobiliyatini ochib beradi. Precigen, Inc. (PGEN) uchun 21.40 qiymati sintez avtomatlashtiruvi va majburiy klinik sinovlar xarajatlari o'rtasidagi muvozanatni aks ettiradi. GURU.Markets platformasida operatsion marja tendentsiyasini tahlil qilish orqali investor barqaror kapital himoyasini stagnatsiya xavfidan ajratib olishi mumkin.

Precigen, Inc. raqobatchilari tahlili

ARGX (argenx N.V.) - Operatsion marja|Sotuvning operatsion rentabelligi BioNTech Pharma BNTX|Sotuvning operatsion marjasi ABVX (ABIVAX)|Operatsion marja ADMA Biologics, Inc. (ADMA)|Operatsion marja PTGX (protagonist-inc.com)|IMVT: Operatsion foyda bo'yicha sotuv rentabelligi|KNSA - Operatsion rentabellik|GRFS: Operatsion rentabellik|ADPT (Adaptive Biotechnologies) - Sotuvning operatsion marjasi|Operatsion foyda bo'yicha sotuv rentabelligi CLDX|Sotuvning operatsion marjasi AUPH|BCRX (BioCryst Pharmaceuticals) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Vera Pharma (VERA)|DNTH (Dianthus Therapeutics) - Operatsion foyda normasi|Pharvaris N.V. - Sotuvning operatsion marjasi|Operatsion foyda normasi ABCL|TRML: Sotuvning operatsion marjasi|Operatsion foyda normasi PHAR (Pharming Group NV)|NKTR: Operatsion marja|Upstream Bio Corp - Operatsion foyda normasi|Operatsion rentabellik Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Operatsion faoliyat rentabelligi|Operatsion marja GOSS|Sotuvning operatsion marjasi KalVista Pharmaceuticals, Inc. KALV|Operatsion rentabellik Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Sotuvning operatsion rentabelligi|SVRA - Operatsion rentabellik|Rigel Pharmaceuticals - Operatsion foyda koeffitsiyenti|AnaptysBio Corp (ANAB) - Operatsion rentabellik|ATXS - Operatsion faoliyat rentabelligi|Operatsion rentabellik enGene Holdings Inc.|RAPT: Operatsion foyda normasi|Operatsion marja JBIO|Sotuvning operatsion marjasi aclaristx.com ACRS|Operatsion rentabellik Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Sotuvning operatsion rentabelligi|Cabaletta Bio, Inc - Operatsion marja|Sotuvning operatsion rentabelligi Ventyx Biosciences|THTX (theratech.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Operatsion marja|Sotuvning operatsion rentabelligi Agenus Inc. AGEN|Sotuvning operatsion marjasi CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Operatsion foyda normasi|Operatsion rentabellik atyrpharma.com ATYR|Operatsion marja Adagene Corp ADAG|IMA - Operatsion rentabellik|Operatsion foyda normasi STTK (Shattuck Labs)|EQ: Operatsion marja|Connect Biopharma (CNTB) - Operatsion marja|Operatsion rentabellik Immunic|Operatsion marja atarabio.com|Operatsion marja IFRX|Operatsion marja X4 Pharma (XFOR)|Operatsion marja ACET (adicetbio.com)|Operatsion marja Celularity Inc. CELU|INMB - Operatsion rentabellik|Operatsion foyda normasi BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi SAB Biotherapeutics Inc.|Sotuvning operatsion marjasi AKTX|Sotuvning operatsion marjasi enlivex.com (ENLV)|Operatsion rentabellik Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Operatsion foyda bo'yicha marjinallik|Operatsion marja EDSA (Edesa Biotech Corp)|Operatsion faoliyat rentabelligi iBio (IBIO)|CARM - Operatsion rentabellik|XTL Biopharmaceuticals (XTLB) - Sotuvning operatsion marjasi|BOLT: Operatsion marja|Sotuvning operatsion marjasi HCW Biologics Inc.|Operatsion rentabellik Aptevo|Operatsion foyda bo'yicha sotuv rentabelligi AIM (AIM ImmunoTech, Inc.)|Operatsion marja ADTX|Operatsion faoliyat rentabelligi GRI Bio Corp|Operatsion marja XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Sotuvning operatsion rentabelligi|Revelation Biosciences Corp - Operatsion marja|INDP (Indaptus Therapeutics, Inc.) - Operatsion foyda bo'yicha sotuv rentabelligi|SCNI: Operatsion marja|CALI - Operatsion faoliyat rentabelligi|AFMD (Affimed N.V.) - Operatsion marja|Operatsion rentabellik ALLK|Sotuvning operatsion marjasi HOOK (HOOKIPA Pharma, Inc.)|IGMS - Sotuvning operatsion rentabelligi|Operatsion rentabellik iTeos ITOS|Ocean Bio - Operatsion rentabellik|TC BioPharm Ltd - Operatsion marja|Sotuvning operatsion rentabelligi thirdharmonicbio.com